Price (delayed)
$14.75
Market cap
$1.12B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.37
Enterprise value
$1.08B
Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. The Company is leveraging its proprietary switch-control kinase
There are no recent dividends present for DCPH.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.